Dan, age 45, is obese and has type 2 diabetes and has been having trouble getting his glycohemoglobin under control. He's heard
that Exenatide (Byetta) causes weight loss and wants to try it. What do you tell him? a. "Lets just adjust your oral antidiabetic agents instead."
b. "That's a myth. People usually change their eating habits when taking this and that's what causes the weight loss."
c. "With type 2 diabetes, you never want to be on injectable insulin
d. "Let's try it. You're glycohemoglobin will be lowered and you may lose weight."
Answer: d) "Let's try it. Your glycohemoglobin will be lowered and you may lose weight."
Explanation:
Dan can try Byetta since he is a type 2 diabetic, and Byetta is strictly for type 2 diabetes.
Byetta (Exenatide) is a man-made hormone injectible drug (incretin mimetics) which is used to treat people with type 2 diabetes. It helps lower blood sugar levels by increasing the secretion of insulin from the pancreas, which decreases the action of glucagon and slows down the absorption of glucose from the gut.
It reduces appetite, which is an advantage for Dan because it can help him achieve weight loss.
